-
Symbol
-
XLO on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
4,347,826 shares
-
Security Ownership %
-
9%
AbbVie Inc. ownership in Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)
18 Feb 2025 - AbbVie Inc. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,347,826 shares of Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO).
This represents 9% ownership of the company.
This is the first filing by AbbVie Inc. disclosing ownership of Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO).